MedPath
FDA Approval

Clopidogrel bisulfate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
September 30, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Clopidogrel(75 mg in 1 1)

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

DR. REDDY'S LABORATORIES LIMITED (FTO-Sez-Process Unit-01)

Dr.Reddy's Laboratories Limited

860037244

Dr.Reddy's Laboratories Limited

Dr.Reddy's Laboratories Limited

918608162

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Clopidogrel bisulfate

Product Details

NDC Product Code
55111-196
Application Number
ANDA076273
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 30, 2022
Code: 08I79HTP27Class: ACTIMQuantity: 75 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
Croscarmellose SodiumInactive
Code: M28OL1HH48Class: IACT
MannitolInactive
Code: 3OWL53L36AClass: IACT
Hypromellose 2910 (5 Mpa.S)Inactive
Code: R75537T0T4Class: IACT
Cellulose, MicrocrystallineInactive
Code: OP1R32D61UClass: IACT
Polyethylene Glycol 400Inactive
Code: B697894SGQClass: IACT
titanium dioxideInactive
Code: 15FIX9V2JPClass: IACT
Magnesium StearateInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath